Canada Markets closed

KetamineOne Capital Limited (MEDI.NE)

NEO - NEO Real Time Price. Currency in CAD
Add to watchlist
0.58000.0000 (0.00%)
At close: 3:59PM EDT
Full screen
Previous Close0.5800
Open0.5500
Bid0.5500 x N/A
Ask0.5800 x N/A
Day's Range0.5300 - 0.5900
52 Week Range0.1300 - 1.9000
Volume26,446
Avg. Volume0
Market Cap59.943M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.0530
Earnings DateJun. 15, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    Ketamine One Launching Two Inaugural Research Studies

    The Single-Arm Studies Will Be Focused on Treatment-Resistant Depression and Post-Traumatic Stress DisorderVANCOUVER, British Columbia, Oct. 14, 2021 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited (“Ketamine One” or the “Company”) (NEO: MEDI) (OTC: KONEF) (Frankfurt: MY0), a company focused on consolidating medical clinics and becoming a North American leader in mental health treatments, is pleased to announce that it will be launching a single arm, open label study of patients with post-trauma

  • GlobeNewswire

    Ehave Hires Contract Research Organization To Conduct Ketamine Clinical Trial In Miami, Florida

    Ehave one of the first companies to pioneer the collection of certain data points, as well as to seek to understand how ketamine can potentially resolve issues in the brain through a process called neuroplasticityMIAMI, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today it has hired KGK Science Inc., a contract research organization (CRO) that is wholly-owned by Ketamin

  • GlobeNewswire

    Ketamine One Subsidiary KGK Science Contracted to Support a Ketamine Clinical Trial in the United States

    The Trial is to be Conducted in Association with a Clinic Operator in its Facilities Located in Miami, FloridaVANCOUVER, British Columbia, Oct. 06, 2021 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited (“Ketamine One” or the “Company”) (NEO: MEDI) (OTC: KONEF) (Frankfurt: MY0), a company focused on consolidating medical clinics and becoming a North American leader in mental health treatments, is pleased to announce that its wholly-owned contract research organization, KGK Science Inc. (“KGK” or t